Using a CRISPR KO screen targeting 64 KGDDs, we identified and validated TMLHE as the aKGDD driving these effects
STEP THREE Using our advanced InBody scanner, we analyze your: Muscle and fat distribution Visceral Fat Hydration levels Basal metabolic rate (BMR) and Body Mass Index(BMI) The InBody Composition evaluation gives us the information to create a targeted plan for a successful weight loss and wellness journey
Symptoms overlap across diagnoses
Author contributions All authors above made substantial contributions to the conception or design of the work or the acquisition, analysis or interpretation of data for the work and drafting the work or revising it critically for important intellectual content and gave final approval of the version to be published and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved
* The unique structural changes allow EPA and DHA to bypass this blockade
References Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al